Projects and Grants per year
Grants and Contracts Details
Description
Pharmacists are highly trained healthcare professionals with great ability to impact patient and
public health, yet remain grossly underutilized within the healthcare community. Community
pharmacists offer unparalleled access points for OUD treatment, overdose prevention and
related harm reduction services, with at least one community pharmacy located in 119 of
Kentucky's 120 counties. Pharmacists are participating in VivitrolÆÊ programs currently at two
sites in KY ¡V Bluegrass Community Health Center in Lexington and St. Matthews Community
Pharmacy in Louisville. and have established successful collaborative relationships with drug
court officials and OUD treatment providers that we can use to develop our care delivery
model. UK's CAPP has relationships with community pharmacists across the state and led the
development of the training program required by the Board of Pharmacy to implement SB 192
which since May, 2015, has been used to train more than 1700 pharmacists and student
pharmacists.
In this pilot project, we will partner with pharmacists from Bluegrass Community Health Center
in Lexington (Tera McIntosh) and St Matthews Community Pharmacy in Louisville (Chris Harlow)
to integrate and build on their existing VivitrolÆÊ programs to develop the community pharmacy
care delivery model for VivitrolÆÊ. Training for administration and management of Vivitrol and
implementation of the pharmacy based care delivery model will be developed by the Center for
the Advancement of Pharmacy Practice (CAPP). Once the care delivery model is developed and
select pharmacists trained, we will facilitate collaborations between community pharmacists
and local opioid use disorder (OUD) treatment providers offering psychosocial interventions,
including Kentucky¡¦s 15 Community Mental Health Centers, as well as between local prison and
drug court officials to identify individuals in need of VivitrolÆÊ therapy as they transition from
criminal justice settings.
Pharmacists implementing care delivery model would purchase and maintain VivitrolÆÊ
inventory and would bill Medicaid MCOs or other third-party payers for the medication and its
administration as appropriate. Individuals who are uninsured or whose insurance plan does not
adequately cover the costs of VivitrolÆÊ could receive VivitrolÆÊ purchased by grant funds.
As take home naloxone is indicated for any individual with a history of OUD, pharmacists would
also dispense and educate on use of naloxone. Once the care delivery model is established and
implemented in select pharmacy sites, the program could be scalable to include additional
community pharmacies in areas of highest need.
FREEMAN SCOPE OF WORK
Project Goals:
We propose to increase access to VivitrolÆÊ by:
1) developing a community pharmacy care delivery model for VivitrolÆÊ based MAT
2) training community pharmacists to appropriately administer and manage VivitrolÆÊ therapy
and implement the care delivery model
3) facilitating the establishment of collaborative relationships between officials overseeing
release of incarcerated individuals, drug court officials, community pharmacists and
practitioners who provide psychosocial interventions (CBT) for delivery of quality MAT for
individuals re-entering the community following incarceration or drug court
Status | Finished |
---|---|
Effective start/end date | 7/1/18 → 6/30/20 |
Funding
- KY Cabinet for Health and Family Services
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Projects
- 1 Finished
-
Kentucky Opioid Response Efforts (KORE): First Bridge Clinic
Walsh, S. (PI), Fanucchi, L. (CoI), Freeman, P. (CoI), Lofwall, M. (CoI), McIntosh, T. (CoI), Murphy, J. (CoI), Oller, D. (CoI) & Polly, R. (CoI)
KY Cabinet for Health and Family Services
7/1/18 → 6/30/20
Project: Research project